Slides

Gaucher Disease Module 1 slides

Resources

• National Library of Medicine: Gaucher Disease https://ghr.nlm.nih.gov/condition/gaucher-disease
• National Institute of Neurologic Disorders and Stroke, Gaucher Disease Information Page https://www.ninds.nih.gov/Disorders/All-Disorders/Gaucher-Disease-Information-Page
• Genetic and Rare Disorders Information Center: Gaucher Disease https://rarediseases.info.nih.gov/diseases/8233/gaucher-disease
• National Gaucher Foundation https://www.gaucherdisease.org
• Stirnemann J, Belmatoug N, Camou F, et al. A review of Gaucher disease pathophysiology, clinical presentation, and treatments. Int J Mol Sci. 2017;18(2):441. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343975/.
• Biegstraaten M, Cox TM, Belmatoug N, et al. Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease. Blood Cells Mol Dis. 2018;68:203-08. doi:10.1016/j.bcmd.2016.10.008. Available at https://www.sciencedirect.com/science/article/pii/S1079979616301917?via%3Dihub
• Torralba-Cabeza M-A, Olivera-Gonzalez S, Sierra-Monzon J-L.The importance of a multidisciplinary approach in the management of a patient with type I Gaucher disease. Diseases. 2018;6(3).pii: E69. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164989/pdf/diseases-06-00069.pdf

Provided by

Support for the activities in this curriculum has been made possible through an educational grant from Sanofi Genzyme.

Learning Objective

After participating in the activity, learners should be better able to:

• Describe the clinical picture of Gaucher disease 

Release date: 02/28/19
Reviewed: 01/23/20
Expiration date: 04/15/20
NO LONGER AVAILABLE FOR CREDIT
Estimated time to complete: 0.25 hours

Activity Faculty

Neal Weinreb, MD, FACP
Regional Coordinator and Chair of the International Collaborative Gaucher Group
University of Miami UHealth Sylvester Cancer Center Coral Springs
Coral Springs, FL

Target Audience

The target audience for this initiative is physicians and other providers, including nurse practitioners and physician assistants, who may encounter patients in their practice with undiagnosed Gaucher Disease.

Accreditation and Credit Designation

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation

There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the post-test, and program evaluation. Your certificate can be printed immediately.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Faculty Educator

Dr. Weinreb has the following relationships to disclose:

• Advisory Board for Scientific Information: Genzyme-Sanofi, Pfizer, Shire HGT
• Grant/Research support: Genzyme ICGG Gaucher Registry - PI (University Research Foundation for Lysosomal Storage Diseases Inc)
• Shire HGT Gaucher Outcome Survey: PI (University of Miami Miller School of Medicine; Dept of Human Genetics)

Planning Committee

John JD Juchniewicz, MCIS, CHCP; Paul Miniter, MS; Edward Moylan, RP (reviewer) American Academy of CME, Inc.: No relevant financial relationships with any commercial interests.

Disclaimer

This activity may contain discussion of off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Hardware/Software Requirements

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm For more information about CheckRare’s privacy policy, please access https://checkrare.com/privacy/

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2019. This CME-certified activity is held as copyrighted © by American Academy of CME, Inc.. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).